Search Orphan Drug Designations and Approvals
-
Generic Name: | antibody drug conjugate of metal-binding motif-introduced trastuzumab antibody variant and monomethyl auristatin E |
---|---|
Date Designated: | 07/30/2018 |
Orphan Designation: | Treatment of Gastric Cancer |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Alteogen, Inc. 62 Yuseong-daero 1628beon-gil Yuseong-gu Daejeon, Daejeon South Korea The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-